IRIX Overview

IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Wall Street analysts forecast IRIX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IRIX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

IRIDEX Corp revenue for the last quarter amounts to 12.48M USD, increased 7.80

IRIDEX Corp. EPS for the last quarter amounts to -0.09 USD, decreased -25.00

IRIDEX Corp (IRIX) has 93 emplpoyees as of March 11 2026.

Today IRIX has the market capitalization of 23.03M USD.